Now that we are trying to complete and devise some efforts about how to follow those requirements, it's sometimes being ...

California's top court refused to hold Gilead liable for delaying a safer HIV drug to protect its franchise – a win for ...

Attorneys at NAD's 'Ad Law in Motion' conference in New York said that, under NAD’s definition of advertising, a brand can be ...

Manufacturers could accede to Trump Administration pressure and agree to MFN deals that include participating in the GENEROUS ...

But if the mandatory Most Favored Nation payment model was always meant primarily as a stick to coerce manufacturers into ...

The FDA selected three more technologies for its READI-Home Innovation Challenge, including home blood collection from Becton ...

Amid ongoing geopolitical complexities and “profound transformations” affecting the pharmaceutical industry, French ...

The Vaccines and Related Biological Products Advisory Committee recommended the same influenza A and B strains found in the ...

The company said it plans to file for approval of the azacitidine/cedazuridine combination pill in myelodysplastic syndromes ...

Orifarm has today unveiled a five-year plan that will see it push into new markets across Europe, with a “significant ...

IL-4 and TSLP with Pfizer’s trispecific antibody, which the firm has moved into Phase III studies in two indications, ...

The National Advertising Division discusses its new or strengthened partnerships with recipient organizations to improve the ...